Clinical and dietary predictors of common carotid artery intima media thickness in a population with type 1 and type 2 diabetes: A cross-sectional study.

Journal Information

Full Title: World J Diabetes

Abbreviation: World J Diabetes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict-of-interest statement: The authors declare that they have no conflicts of interest."

Evidence found in paper:

"The authors of this study would like to acknowledge the contributions of study participants and the staff of the University of South Australia. Peter J Meikle is supported by a NHMRC senior research fellowship (1042095). This work was supported by the OIS Program of the Victorian Government, Australia. Jennifer B Keogh is a Fellow of the South Australian Cardiovascular Research Development Program funded by the Heart Foundation and the Government of South Australia. Peter M Clifton is supported by a NHMRC Principal Research Fellowship. Kristina S Petersen is funded by an Australian Postgraduate Award + UniSA Rural and Isolated Top-up Scholarship. This research was jointly funded through these fellowships and the University of South Australia."

Evidence found in paper:

"This is a cross-sectional study investigating the predictors of CCA IMT in subjects with type 1 and type 2 diabetes. One hundred and fifty subjects were recruited by public advertisement between August 2012 and December 2013. Subjects eligible for inclusion were adults (age > 18 years) with diagnosed type 1 or type 2 diabetes for any duration, managed with diet, oral hypoglycaemic agents and/or insulin. Subjects were excluded if they reported having cancer, unstable CVD requiring intervention, heart failure, significant renal impairment (eGFR < 30 mL/min) or liver disease. Ethics approval was obtained from the University of South Australia Human Research Ethics Committee and all participants provided written informed consent. The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12612001052820)."

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025